je.st
news
Houston biotech company raises $140M in upsized IPO
2014-12-19 14:41:04| Biotech - Topix.net
Bellicum Pharmaceuticals Inc. raised $139.65 million when it priced its upsized initial public offering at $19 per share on Dec. 18. Bellicum, a Houston-based biotechnology company focused on developing cell therapies to treat and prevent cancer, offered 7.35 million shares of its common stock. That's up 1.1 million shares from what it had initially planned, according to the company .
Tags: company
houston
ipo
raises
Category:Biotechnology and Pharmaceuticals